Literature DB >> 22226846

Structure and function of OprD protein in Pseudomonas aeruginosa: from antibiotic resistance to novel therapies.

Hui Li1, Yi-Feng Luo, Bryan J Williams, Timothy S Blackwell, Can-Mao Xie.   

Abstract

Pseudomonas aeruginosa (P. aeruginosa) is a common pathogen isolated from patients with nosocomial infections. Due to its intrinsic and acquired antimicrobial resistance, limited classes of antibiotics can be used for the treatment of infection with P. aeruginosa. Of these, the carbapenems are very important; however, the occurrence of carbapenem-resistant strains is gradually increasing over time. Deficiency of the outer membrane protein OprD confers P. aeruginosa a basal level of resistance to carbapenems, especially to imipenem. Functional studies have revealed that loops 2 and 3 in the OprD protein contain the entrance and/or binding sites for imipenem. Therefore, any mutation in loop 2 and/or loop 3 that causes conformational changes could result in carbapenem resistance. OprD is also a common channel for some amino acids and peptides, and competition with carbapenems through the channel may also occur. Furthermore, OprD is a highly regulated protein at transcriptional and post-transcriptional levels by some metals, small bioactive molecules, amino acids, and efflux pump regulators. Because of its hypermutability and highly regulated properties, OprD is thought to be the most prevalent mechanism for carbapenem resistance in P. aeruginosa. Developing new strategies to combat infection with carbapenem-resistant P. aeruginosa lacking OprD is an ongoing challenge. Copyright Â
© 2011 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22226846      PMCID: PMC3831278          DOI: 10.1016/j.ijmm.2011.10.001

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  60 in total

1.  Structural insight into OprD substrate specificity.

Authors:  Shyamasri Biswas; Mohammad M Mohammad; Dimki R Patel; Liviu Movileanu; Bert van den Berg
Journal:  Nat Struct Mol Biol       Date:  2007-10-21       Impact factor: 15.369

2.  Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates.

Authors:  John Quale; Simona Bratu; Jyoti Gupta; David Landman
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

3.  In vitro and in vivo activities of a new cephalosporin, FR264205, against Pseudomonas aeruginosa.

Authors:  Shinobu Takeda; Toru Nakai; Yoshimi Wakai; Fumiaki Ikeda; Kazuo Hatano
Journal:  Antimicrob Agents Chemother       Date:  2006-12-04       Impact factor: 5.191

4.  Polyamine effects on antibiotic susceptibility in bacteria.

Authors:  Dong-Hyeon Kwon; Chung-Dar Lu
Journal:  Antimicrob Agents Chemother       Date:  2007-04-16       Impact factor: 5.191

5.  Sequence diversity of the OprD protein of environmental Pseudomonas strains.

Authors:  Sylvie Chevalier; Josselin Bodilis; Thomas Jaouen; Sylvie Barray; Marc G J Feuilloley; Nicole Orange
Journal:  Environ Microbiol       Date:  2007-03       Impact factor: 5.491

Review 6.  Comparative review of the carbapenems.

Authors:  George G Zhanel; Ryan Wiebe; Leanne Dilay; Kristjan Thomson; Ethan Rubinstein; Daryl J Hoban; Ayman M Noreddin; James A Karlowsky
Journal:  Drugs       Date:  2007       Impact factor: 9.546

7.  Levofloxacin/imipenem prevents the emergence of high-level resistance among Pseudomonas aeruginosa strains already lacking susceptibility to one or both drugs.

Authors:  Philip D Lister; Daniel J Wolter; Paul A Wickman; Mark D Reisbig
Journal:  J Antimicrob Chemother       Date:  2006-03-02       Impact factor: 5.790

8.  Emergence of carbapenem resistance in Pseudomonas aeruginosa isolates from a patient with cystic fibrosis in the absence of carbapenem therapy.

Authors:  Daniel J Wolter; Dee Acquazzino; Richard V Goering; Paul Sammut; Noha Khalaf; Nancy D Hanson
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

9.  Role of outer membrane protein OprD and penicillin-binding proteins in resistance of Pseudomonas aeruginosa to imipenem and meropenem.

Authors:  Anna Farra; Sohidul Islam; Annelie Strålfors; Mikael Sörberg; Bengt Wretlind
Journal:  Int J Antimicrob Agents       Date:  2008-03-28       Impact factor: 5.283

10.  A copper-activated two-component system interacts with zinc and imipenem resistance in Pseudomonas aeruginosa.

Authors:  Olivier Caille; Claude Rossier; Karl Perron
Journal:  J Bacteriol       Date:  2007-04-20       Impact factor: 3.490

View more
  61 in total

1.  Probing the binding affinities of imipenem and ertapenem for outer membrane carboxylate channel D1 (OccD1) from P. aeruginosa: simulation studies.

Authors:  Kamolrat Somboon; Jitti Niramitranon; Prapasiri Pongprayoon
Journal:  J Mol Model       Date:  2017-07-17       Impact factor: 1.810

2.  Identification of outer membrane Porin D as a vitronectin-binding factor in cystic fibrosis clinical isolates of Pseudomonas aeruginosa.

Authors:  Magnus Paulsson; Birendra Singh; Tamim Al-Jubair; Yu-Ching Su; Niels Høiby; Kristian Riesbeck
Journal:  J Cyst Fibros       Date:  2015-06-03       Impact factor: 5.482

3.  Antimicrobial Effect of Imipenem-Functionalized Fe2O3 Nanoparticles on Pseudomonas aeruginosa Producing Metallo β-lactamases.

Authors:  Mohammad Reza Khataminejad; Reza Mirnejad; Malike Sharif; Mojtaba Hashemi; Nikita Sajadi; Vahhab Piranfar
Journal:  Iran J Biotechnol       Date:  2015-12       Impact factor: 1.671

4.  Uncoupled Quorum Sensing Modulates the Interplay of Virulence and Resistance in a Multidrug-Resistant Clinical Pseudomonas aeruginosa Isolate Belonging to the MLST550 Clonal Complex.

Authors:  Tingying Xia; Yanran Li; Zeling Xu; Huiluo Cao; Salim Bougouffa; Yat Kei Lo; Vladimir B Bajic; Haiwei Luo; Patrick C Y Woo; Aixin Yan
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

5.  Global Dynamic Proteome Study of a Pellicle-forming Acinetobacter baumannii Strain.

Authors:  Takfarinas Kentache; Ahmed Ben Abdelkrim; Thierry Jouenne; Emmanuelle Dé; Julie Hardouin
Journal:  Mol Cell Proteomics       Date:  2016-10-31       Impact factor: 5.911

6.  Molecular epidemiology and mechanisms of antimicrobial resistance in Pseudomonas aeruginosa isolates causing burn wound infection in Iran.

Authors:  Hossein Fazeli; Hooman Sadighian; Bahram Nasr Esfahani; Mohammad Reza Pourmand
Journal:  J Chemother       Date:  2013-12-06       Impact factor: 1.714

Review 7.  New β-Lactam-β-Lactamase Inhibitor Combinations.

Authors:  Dafna Yahav; Christian G Giske; Alise Grāmatniece; Henrietta Abodakpi; Vincent H Tam; Leonard Leibovici
Journal:  Clin Microbiol Rev       Date:  2020-11-11       Impact factor: 26.132

8.  Molecular Epidemiology of Mutations in Antimicrobial Resistance Loci of Pseudomonas aeruginosa Isolates from Airways of Cystic Fibrosis Patients.

Authors:  Leonie Greipel; Sebastian Fischer; Jens Klockgether; Marie Dorda; Samira Mielke; Lutz Wiehlmann; Nina Cramer; Burkhard Tümmler
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

9.  Probing the sRNA regulatory landscape of P. aeruginosa: post-transcriptional control of determinants of pathogenicity and antibiotic susceptibility.

Authors:  Yi-Fan Zhang; Kook Han; Courtney E Chandler; Brian Tjaden; Robert K Ernst; Stephen Lory
Journal:  Mol Microbiol       Date:  2017-11-02       Impact factor: 3.501

10.  The fatty acid signaling molecule cis-2-decenoic acid increases metabolic activity and reverts persister cells to an antimicrobial-susceptible state.

Authors:  Cláudia N H Marques; Aleksey Morozov; Penny Planzos; Hector M Zelaya
Journal:  Appl Environ Microbiol       Date:  2014-09-05       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.